Search Results - "Sawyer, Douglas B."

Refine Results
  1. 1

    Neuregulins: protective and reparative growth factors in multiple forms of cardiovascular disease by Geissler, Andrew, Ryzhov, Sergey, Sawyer, Douglas B

    Published in Clinical science (1979) (01-10-2020)
    “…Neuregulins (NRGs) are protein ligands that act through ErbB receptor tyrosine kinases to regulate tissue morphogenesis, plasticity, and adaptive responses to…”
    Get more information
    Journal Article
  2. 2

    Neuregulin in Cardiovascular Development and Disease by Odiete, Oghenerukevwe, Hill, Michael F, Sawyer, Douglas B

    Published in Circulation research (26-10-2012)
    “…Studies in genetically modified mice have demonstrated that neuregulin-1 (NRG-1), along with the erythroblastic leukemia viral oncogene homolog (ErbB) 2, 3,…”
    Get full text
    Journal Article
  3. 3

    Endothelial Cells Regulate Physiological Cardiomyocyte Growth via VEGFR2-Mediated Paracrine Signaling by Kivelä, Riikka, Hemanthakumar, Karthik Amudhala, Vaparanta, Katri, Robciuc, Marius, Izumiya, Yasuhiro, Kidoya, Hiroyasu, Takakura, Nobuyuki, Peng, Xuyang, Sawyer, Douglas B, Elenius, Klaus, Walsh, Kenneth, Alitalo, Kari

    Published in Circulation (New York, N.Y.) (28-05-2019)
    “…BACKGROUND:Heart failure, which is a major global health problem, is often preceded by pathological cardiac hypertrophy. The expansion of the cardiac…”
    Get full text
    Journal Article
  4. 4

    Oxidative Stress in Heart Failure: What Are We Missing? by Sawyer, Douglas B., MD, PhD

    “…Abstract Over the past several decades, investigations in humans and animal models of heart failure (HF) have provided substantial evidence that oxidative…”
    Get full text
    Journal Article Conference Proceeding
  5. 5

    Anthracycline Cardiotoxicity: From Bench to Bedside by GIANNI, Luca, HERMAN, Eugene H, LIPSHULTZ, Steven E, MINOTTI, Giorgio, SARVAZYAN, Narine, SAWYER, Douglas B

    Published in Journal of clinical oncology (01-08-2008)
    “…Anthracyclines remain among the most widely prescribed and effective anticancer agents. Unfortunately, life-threatening cardiotoxicity continues to compromise…”
    Get full text
    Journal Article
  6. 6

    Mechanisms of Anthracycline Cardiac Injury: Can We Identify Strategies for Cardioprotection? by Sawyer, Douglas B, Peng, Xuyang, Chen, Billy, Pentassuglia, Laura, Lim, Chee Chew

    Published in Progress in cardiovascular diseases (01-09-2010)
    “…Abstract Anthracycline antibiotics have saved the lives of many cancer victims in the 50 plus years since their discovery. A major limitation of their use is…”
    Get full text
    Journal Article
  7. 7

    3D Co-culture of hiPSC-Derived Cardiomyocytes With Cardiac Fibroblasts Improves Tissue-Like Features of Cardiac Spheroids by Beauchamp, Philippe, Jackson, Christopher B, Ozhathil, Lijo Cherian, Agarkova, Irina, Galindo, Cristi L, Sawyer, Douglas B, Suter, Thomas M, Zuppinger, Christian

    Published in Frontiers in molecular biosciences (14-02-2020)
    “…Both cardiomyocytes and cardiac fibroblasts (CF) play essential roles in cardiac development, function, and remodeling. Properties of 3D co-cultures are…”
    Get full text
    Journal Article
  8. 8

    Heat shock proteins in cancer: chaperones of tumorigenesis by Calderwood, Stuart K., Khaleque, Md Abdul, Sawyer, Douglas B., Ciocca, Daniel R.

    “…The heat shock proteins (HSPs) induced by cell stress are expressed at high levels in a wide range of tumors and are closely associated with a poor prognosis…”
    Get full text
    Journal Article
  9. 9

    ErbB/integrin signaling interactions in regulation of myocardial cell–cell and cell–matrix interactions by Pentassuglia, Laura, Sawyer, Douglas B.

    Published in Biochimica et biophysica acta (01-04-2013)
    “…Neuregulin (Nrg)/ErbB and integrin signaling pathways are critical for the normal function of the embryonic and adult heart. Both systems activate several…”
    Get full text
    Journal Article
  10. 10

    Heart Transplant Survival Outcomes for Adriamycin-Dilated Cardiomyopathy by Lenneman, Andrew J., MD, Wang, Li, MS, Wigger, Mark, MD, Frangoul, Haydar, MD, Harrell, Frank E., PhD, Silverstein, Cheri, MD, Sawyer, Douglas B., MD, PhD, Lenneman, Carrie G., MD, MSCI

    Published in The American journal of cardiology (15-02-2013)
    “…In 2015, there will be an estimated 11.3 million cancer survivors. With an increasing population of cancer survivors, it is imperative to understand the…”
    Get full text
    Journal Article
  11. 11

    Vascular Endothelial Growth Factor Blockade Promotes the Transition From Compensatory Cardiac Hypertrophy to Failure in Response to Pressure Overload by Izumiya, Yasuhiro, Shiojima, Ichiro, Sato, Kaori, Sawyer, Douglas B, Colucci, Wilson S, Walsh, Kenneth

    Published in Hypertension (Dallas, Tex. 1979) (01-05-2006)
    “…Cardiac hypertrophy is associated with upregulation of vascular endothelial growth factor (VEGF) in the myocardium. Here, we evaluated the effects of a decoy…”
    Get full text
    Journal Article
  12. 12

    Circulating growth factors and cardiac remodeling in the community: The Framingham Heart Study by Castro-Diehl, Cecilia, Song, Rebecca J., Sawyer, Douglas B., Wollert, Kai C., Mitchell, Gary F., Cheng, Susan, Vasan, Ramachandran S., Xanthakis, Vanessa

    Published in International journal of cardiology (15-04-2021)
    “…Cardiac and vascular growth factors (GF) may influence myocardial remodeling through cardiac growth and angiogenic effects. We hypothesized that concentrations…”
    Get full text
    Journal Article
  13. 13

    Disruption of a GATA4/Ankrd1 signaling axis in cardiomyocytes leads to sarcomere disarray: implications for anthracycline cardiomyopathy by Chen, Billy, Zhong, Lin, Roush, Sarah F, Pentassuglia, Laura, Peng, Xuyang, Samaras, Susan, Davidson, Jeffrey M, Sawyer, Douglas B, Lim, Chee Chew

    Published in PloS one (20-04-2012)
    “…Doxorubicin (Adriamycin) is an effective anti-cancer drug, but its clinical usage is limited by a dose-dependent cardiotoxicity characterized by widespread…”
    Get full text
    Journal Article
  14. 14

    Circulating vascular endothelial growth factor and the risk of cardiovascular events by Kaess, Bernhard M, Preis, Sarah R, Beiser, Alexa, Sawyer, Douglas B, Chen, Tai C, Seshadri, Sudha, Vasan, Ramachandran S

    Published in Heart (British Cardiac Society) (01-12-2016)
    “…To investigate the relation of circulating concentrations of vascular endothelial growth factor (VEGF) for the risk of developing cardiovascular disease (CVD)…”
    Get more information
    Journal Article
  15. 15

    Anthracyclines and Heart Failure by Sawyer, Douglas B

    Published in The New England journal of medicine (21-03-2013)
    “…Doxorubicin and other anthracyclines are used to treat cancer, yet they elevate the risk of heart failure. A recent study provides insight into how doxorubicin…”
    Get full text
    Journal Article
  16. 16

    What is Quality End-of-Life Care for Patients With Heart Failure? A Qualitative Study With Physicians by Hutchinson, Rebecca N, Gutheil, Caitlin, Wessler, Benjamin S, Prevatt, Hayley, Sawyer, Douglas B, Han, Paul K J

    Published in Journal of the American Heart Association (15-09-2020)
    “…Background Advanced heart failure (AHF) carries a morbidity and mortality that are similar or worse than many advanced cancers. Despite this, there are no…”
    Get full text
    Journal Article
  17. 17

    Neuregulin (NRG-1β) Is Pro-Myogenic and Anti-Cachectic in Respiratory Muscles of Post-Myocardial Infarcted Swine by Galindo, Cristi L, Nguyen, Van Thuan, Hill, Braxton, Easterday, Ethan, Cleator, John H, Sawyer, Douglas B

    Published in Biology (Basel, Switzerland) (29-04-2022)
    “…Neuregulin-1β (NRG-1β) is a growth and differentiation factor with pleiotropic systemic effects. Because NRG-1β has therapeutic potential for heart failure and…”
    Get full text
    Journal Article
  18. 18

    DEspRhigh neutrophils are associated with critical illness in COVID-19 by deKay, Joanne T., Emery, Ivette F., Rud, Jonathan, Eldridge, Ashley, Lord, Christine, Gagnon, David J., May, Teresa L., Herrera, Victoria L. M., Ruiz-Opazo, Nelson, Riker, Richard R., Sawyer, Douglas B., Ryzhov, Sergey, Seder, David B.

    Published in Scientific reports (17-11-2021)
    “…SARS-CoV-2 infection results in a spectrum of outcomes from no symptoms to widely varying degrees of illness to death. A better understanding of the immune…”
    Get full text
    Journal Article
  19. 19

    Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatment by Lenneman, Carrie G, Sawyer, Douglas B

    Published in Circulation research (18-03-2016)
    “…Through the success of basic and disease-specific research, cancer survivors are one of the largest growing subsets of individuals accessing the healthcare…”
    Get full text
    Journal Article
  20. 20